中国社区医师Issue(1)：30-30,32,2.DOI:10.3969/j.issn.1007-614x.2015.1.17
ST段抬高型急性心肌梗死行强化他汀治疗的疗效及安全性分析
Efficacy and safety of strengthening statin therapy in ST segment elevation acute myocardial infarction
摘要
Abstract
Objective:To explore the efficacy and safety of strengthening statin therapy in ST segment elevation acute myocardial infarction.Methods:106 patients with ST segment elevation acute myocardial infarction were selected from April 2013 to April 2014.They were randomly divided into the study group and the control group with 53 cases in each group.Two groups were given routine therapy.The study group added atorvastatin 40 mg/day.The control group added atorvastatin 20 mg/day.We compared the efficacy and the incidence of cardiovascular event of the two groups.Results:In the study group,the decline rate of Hs-CRP,TC and LDC-C was obviously higher than that of the control group(P<0.05),and there was no significant difference of CK,HDL-C and TG changes of the two groups(P>0.05);in the study group,the incidence rate of cardiovascular events was 3.77%,which was significantly lower than the control group with 20.75%(P<0.05).Conclusion:The efficacy of strengthening statin therapy in ST segment elevation acute myocardial infarction is significant.关键词
ST段抬高型/急性心肌梗死/阿托伐他汀Key words
ST segment elevation/Acute myocardial infarction/Atorvastatin引用本文复制引用
赵强,王辉宇,张海勤..ST段抬高型急性心肌梗死行强化他汀治疗的疗效及安全性分析[J].中国社区医师,2015,(1):30-30,32,2.
